This is a CancerMoonshot. China is moving forward with the first ever human trials to use the CRISPR–Cas9 gene-editing technique to treat lung cancer in August 2016. Similar to the CAR-T Immunotherapy approach, Chinese scientists will extract T cells from NSCLC patients blood and use CRISPR to “knock out” a gene that encodes the PD-1 protein. The gene-edited cells will then be multiplied in the lab and re-introduced into the patient’s bloodstream. The engineered cells will circulate and hopefully attack the cancer. Editing the gene with CRISPR to block PD-1 may be a more efficient and powerful method than using checkpoint inhibitors like nivolumab (Opdivo) or pembrolizumab (Keytruda). This is one to watch!! https://www.statnews.com/2016/…/21/crispr-experiment-humans/ http://www.nature.com/…/chinese-scientists-to-pioneer-first…


This is a CancerMoonshot. China is moving forward with the first ever human trials to use the CRISPR–Cas9 gene-editing technique to treat lung cancer in August 2016. Similar to the […]

Read Article →

“263 million children & youth, aged between 6 and 17 years old, are not in school. Most are girls.” ~Irina Bokova, Director-General of ‪#‎UNESCO‬ Help Help Help Someone who needs your Help, Help whatever way you can, be the first one to Help. ‪#‎HLPF2016‬ ‪#‎LeaveNoOneBehind‬ ‪#‎SDG4‬ ‪#‎2030Agenda‬ ‪#‎SDGs‬ ‪#‎STEM‬ ‪#‎21Sept‬ ‪#‎PeaceDay‬ ‪#‎UN‬ ‪#‎Peace‬


“263 million children & youth, aged between 6 and 17 years old, are not in school. Most are girls.” ~Irina Bokova, Director-General of ‪#‎UNESCO‬ Help Help Help Someone who needs […]

Read Article →